Enliven: Biosimilars and Bioavailability | Open Access Journals | Open Access Articles




Enliven: Biosimilars and Bioavailablity is an Open access, peer reviewed international journal and it aims to publish different types of articles on emerging developments and supports current and upcoming research in the field of biostatistics. This journal also allows articles on biosimilars, bioavailability and drug delivery systems.

This journal will support the budding scientists, scholars, academicians, researchers, and students by providing Open access platform for publishing their work.

This journal will follow the peer review policies and will bode Open access in having quality research output.


This journal combines the innovative scientific ideas and ways in biosimilars, bioavailability, drug delivery systems and all other related disciplines to have an innovative output.


This journal accepts articles from different disciplines as below but not constrained to only these


Pharmacokinetics
Biopharmaceutics
Bioequivalence
Bioequivalence and simulation
Biosimilars requirement
Biowaivers
Bioavailability enhancement
Drug delivery systems
Drug delivery pathway
Biosimilars oncology
Biosimilars – regulatory affairs
Biosimilars and pharmacology
Drug development systems
Bioavailability
Biosimilars models
General bioequivalence
Bioavailability metrics


Enliven: Biosimilars and Bioavailablity invites articles from authors and we assure authors that articles received will be processed with the best policies and will disseminate the articles to the right field.